Patents by Inventor Zeqiang Xie

Zeqiang Xie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMIDAZOLOPYRIDAZINE OR PYRAZOLOPYRIMIDINE COMPOUNDS AND COMPOSITIONS
    Publication number: 20240335443
    Abstract: Provided herein are novel compounds (e.g., Formula I or II), pharmaceutical compositions, and methods of using related to Tyrosine kinase 2 (TYK2). The compounds herein are typically TYK2 inhibitors, which can be used for treating a variety of diseases or disorders, such as an autoimmune disorder or an inflammatory disorder, e.g., psoriasis, psoriatic arthritis, Crohn's disease, ulcerative colitis, inflammatory bowel disease, and/or systemic lupus erythematosus.
    Type: Application
    Filed: January 18, 2022
    Publication date: October 10, 2024
    Inventors: Dai Cheng, Sen Zeng, Qiming Yue, Zeqiang Xie
  • AMINOHETEROARYL KINASE INHIBITORS
    Publication number: 20240166635
    Abstract: Provided herein are novel compounds (e.g., Formula I or II), pharmaceutical compositions, and methods of using related to cyclin dependent kinases (CDKs). The compounds herein are typically CDK2 inhibitors, which can be used for treating a variety of diseases or disorders, such as cancer.
    Type: Application
    Filed: November 26, 2021
    Publication date: May 23, 2024
    Inventors: Dai Cheng, Qiang Ding, Zhixiang He, Xiaobo Zhou, Yang Zhou, Xiaohang Yin, Zeqiang Xie